Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
4,674,157
-
Share change
-
+218,042
-
Total reported value
-
$16,964,000
-
Price per share
-
$3.63
-
Number of holders
-
21
-
Value change
-
+$766,324
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2020
As of 31 Mar 2020 CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) had 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,674,157 shares of stock of the company.
Largest 10 holders included ARIEL INVESTMENTS, LLC, Stonepine Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, BERKSHIRE ASSET MANAGEMENT LLC/PA, ACADIAN ASSET MANAGEMENT LLC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This table shows 21 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.